Fingerprint
Dive into the research topics of 'Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
Laura Tornatore, Daria Capece, Daniel D'Andrea, Federica Begalli, Daniela Verzella, Jason Bennett, Gary Acton, Elizabeth A. Campbell, James Kelly, Michael Tarbit, Nigel Adams, Selina Bannoo, Antonio Leonardi, Annamaria Sandomenico, Domenico Raimondo, Menotti Ruvo, Angela Chambery, Metod Oblak, Magda J. Al-Obaidi, Richard S. Kaczmarski
- Imperial College London
- Cancer Research UK
- C&C Management Consulting Ltd
- Alpha Preclinical Consultancy
- Independent Consultant
- In2Phase Ltd
- Federico II University
- Sapienza University of Rome
- Università degli Studi della Campania Luigi Vanvitelli
- West Middlesex University Hospital
- Chelsea and Westminister Hospital NHS Foundation Trust
- London Haematology Limited
- St Bartholomew's Hospital Medical College
- Institute of Cancer Research London
- Royal Free London NHS Foundation Trust
- Kings College Hospital
Research output: Contribution to journal › Article › peer-review
13
Citations
(Scopus)
99
Downloads
(Pure)